Fluoxetine Hydrochloride 5.6 mg Oral Chewable Treats (Solid Suspension, 60 x 1 ml Chewable Treats)

Similar documents
Ingredient Listing Qty. Unit NDC # Supplier

Methimazole 5 mg Oral Chewable Treats (Solid Suspension, 60 x 1 ml Treats) FIN F v2. Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier ml

Hydrocortisone 2%, Hydroquinone 6%, Kojic Acid 4%, Salicylic Acid 4%, Tretinoin 0.01% Topical Gel (Suspension, 20 g)

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier g

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

905 UNIFORMITY OF DOSAGE UNITS

Student Practical Guide (1) Milk of Magnesia

247 CMR BOARD OF REGISTRATION IN PHARMACY

INTRODUCTION. Asthma Drug Delivery - 1

Residual Solvents: FDA/ Regulatory Perspective

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry:

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

REVISION OF MONOGRAPH ON TABLETS. Tablets

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

The Therapeutic Goods Act (1989)

The Pharmacy Board of Australia s

CATEGORY IV MONOGRAPH. Athlete's Foot Treatments

KEYWAX WX1014 RUBBER WAX CONCENTRATE

LABELLING STANDARD ANTIFUNGALS (TOPICAL)

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

USP Chewable Gels Monographs

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Suppositories. Suppositories: 08/10/2016

Model Standards for Pharmacy Compounding of Non-Sterile Preparations

Technical Monograph n 17, 2nd Edition. Guidelines for Specifying the Shelf Life of Plant Protection Products

SLEEP AIDS - LABELLING STANDARD

Copyright 2017 PureGreens Nutrition Pte Ltd. All rights reserved. Published by Samuel Grenville.

Food supplement manufacture

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

A. General Appearance

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

Stability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Assessment of Low Dose Content Uniformity of Indomethacin in Excipient Blends Using FT-Raman Mapping Spectroscopy

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

SOFTISAN 100, 142, 154

Easy, fast and reliable!

FLAVOUR FLOW & ADHESION

NATURAL HEALTH PRODUCT FUNGAL PROTEASE

Guidance for Pharmacists on Extemporaneous Dispensing

NEPHROCHECK Calibration Verification Kit Package Insert

ANTACID LABELLING STANDARD

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973

Safety Data Sheet. Product Name: DetectX Glutathione Colorimetric Detection Kit. Section 1: Identification. Section 2: Hazard(s) Identification

INTERNATIONAL STANDARD

FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS

J Pharm Sci Bioscientific Res (4): ISSN NO

Inspection Report Item 29: Compliance with Variance, Specialized Process, Reduced Oxygen Packaging Criteria, and HACCP Plan

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

AgraQuant F.A.S.T. Casein Sandwich ELISA

The Science of Palatability

Curing as a Single Special Process Regulatory Agency Jurisdiction NAME (fill in form)

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

DENTCA Denture Teeth - Directions for Use

LABELLING FOR DISPENSED PRODUCTS

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

VITAMIN D. Proper name(s): Vitamin D (Sweetman 2007; IOM 2003; O Neil et al. 2001)

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Chapter 8. Nonsterile Pharmaceutical Compounding. Paradigm Publishing, Inc. 1

Functional Excipients for Suppository Applications

AGGREGATE WAQTC FOP AASHTO T 2 (16) PERFORMANCE EXAM CHECKLIST (ORAL) Participant Name Exam Date

Prescribing and Dispensing Drugs

STANDARDS FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATIONS

Change to read: BRIEFING

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

THE NOTIFICATION OF MINISTRY OF PUBLIC HEALTH NO. 158 [B.E (1994)] Supplementary Food for Infants and Young Children

MIGLYOL Gel B, Gel T, 840 Gel B

METHOD OF TEST FOR DETERMINATION OF INSOLUBLE RESIDUE OF CARBONATE AGGREGATES

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS. ZINEB Zinc ethylenebisdithiocarbamate

INSTRUCTIONS FOR USE AND CARE

THIS IS UNFPA. Male Latex Condom Testing Guidance UNICEF UNFPA WHO Joint Meeting September David Hill

NEPHROCHECK Liquid Control Kit Package Insert

(12) Patent Application Publication (10) Pub. No.: US 2006/ A1

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

DRIED NOODLES - Indonesia

Recall Guidelines. for Chinese Medicine Products

Title 17-A: MAINE CRIMINAL CODE

MATERIAL SAFETY DATA SHEET

The Liquid Advantage. ...in Mill Applications. Specialized Coating Products For Specialized Mill Manufacturing Needs. Show Feeds.

RealLine HIV quantitative Str-Format

COMMENTARY TO USP31 - NF26

MATERIAL SAFETY DATA SHEET

ab Nuclear Extract Kit

Transcription:

4/11/2015; Page 1 Note: Fluoxetine Hydrochloride 5.6 mg is equivalent to Fluoxetine 5 mg. SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Fluoxetine Hydrochloride, USP 0.336 g Glycerin (A), USP** 6.0 ml Stevia Powder 0.18 g Beef Flavor (Powder) 1.50 g Medisca Gelatin Gum Base TBD Commercial Dried Dog Food Pellets TBD **Note: Caprylic/Capric Triglyceride can be used to replace Glycerin to reduce stickiness. SPECIAL PREPARATORY CONSIDERATIONS Ingredient-Specific Information Lot Number Expiry Date Light sensitive (protect from light whenever possible): Hygroscopic (protect from moisture whenever possible): Fluoxetine Hydrochloride Glycerin, Stevia Powder, Gelatin Gum Base Preparatory Guidelines Non-Sterile Preparation Sterile Preparation Processing Error / Testing Considerations: Special Instruction: To account for processing error considerations during preparation, it is suggested to measure an additional 5 to 9% of the required quantities of ingredients. Protective apparel, such as a lab coat, disposable gloves, eyewear and face-masks should always be worn. This procedure requires the use of very small quantities of ingredients. All calculations and preparation techniques must be verified before dispensing the final product.

4/11/2015; Page 2 SUGGESTED PREPARATION (for 60 x 1 ml Chewable Treats) Weigh and / or measure the following ingredients when appropriate: Ingredient Listing Qty. Unit Multiplication factor (*) : Processing Error Qty. to measure Fluoxetine Hydrochloride, USP 0.336 g Glycerin (A), USP 6.0 ml Stevia Powder 0.18 g Beef Flavor (Powder) 1.50 g Medisca Gelatin Gum Base TBD Commercial Dried Dog Food Pellets TBD * Takes into account increased batch size conversions and density conversions, if required. Weigh / measure just prior to use. 1. Mold calibration: Preparatory Instruction Determine the required quantity of each individual excipient for 60 Chewable Treats. Refer to Appendix for details. 2. Mold lubrication: A. Lubricate all parts of the Chew-A-Treat Mold with suitable vegetable spray and set aside. Note: Selected vegetable spray needs to be compatible with API(s) and all other ingredients within the formulation.

4/11/2015; Page 3 3. Powder preparation: A. Triturate the Commercial Dried Dog Food Pellets (amount calculated in Appendix Step 7Aii) to form a fine, homogeneous powder blend. B. By geometric addition, combine and triturate the following ingredients together to form a fine, homogeneous powder blend. -Fluoxetine Hydrochloride -Beef Flavor (Powder) -Stevia Powder C. By geometric addition, combine and mix the following ingredients together to form a homogeneous mixture: -Fine, homogeneous powder blend (Step 3B) -Fine, homogeneous powder blend (Step 3A) D. Transfer the mixture (Step 3C) to a beaker and incrementally add the Glycerin (A). Specifications: Continuously mix until homogeneous. End result: Homogeneous moist blend. Note: The mixture will have a sand-like texture. If it begins to stick to your stirring device or beaker, you can simply scrape it off and continue mixing. 4. Medium integration: A. Using a sharp blade or scissors, cut and weigh the required quantity of the Gelatin Gum Base (amount calculated in Appendix Step 7Ai). B. Using the hot plate, heat this quantity of Gelatin Gum Base until molten. Specifications: Maintain temperature between 60 C and 65 C. IMPORTANT: Do not allow the temperature to exceed 65 C. C. Using the hot plate, incrementally add the homogeneous moist blend (Step 3D) to the Molten Gelatin Gum Base (Step 4B). Specifications: Continuously mix until homogeneous. Maintain temperature between 60 C and 65 C. End result: Homogeneous thick, sticky paste-like dispersion.

4/11/2015; Page 4 5. Mold filling: A. Properly lubricate gloves (thumbs, forefingers, and palms) throughout filling. B. Continuing to heat the mixture between 60 to 65 C, remove a marble-sized quantity of the mixture at a time and roll it between your thumb and forefinger to form a cylinder. Pack the 60 mold cavities with these cylinders and scrape off any excess with pre-lubricated plastic scraper. C. Once the treats have been packed down with an extractor, apply a thin layer of lubricant to give a shining surface. D. Allow the treats to cool at room temperature for at least 15 minutes and then remove them from the mold using the extractor. 6. Validation technique: A. Weigh 12 chewable treats. B. The final weight of each chewable treat shall not be less than 90% and not more than 110% of the theoretically calculated weight in accordance to USP guidelines. The theoretically calculated weight can be determined by adding the following values: 0.15996 g + [from the Appendix (Step 6Ai/60)]. 7. Product transfer: Transfer the final product into the specified dispensing container (see Packaging Requirements ).

4/11/2015; Page 5 SUGGESTED PRESENTATION Estimated Beyond-Use Date 30 days, as per USP. Packaging Requirements Manually put into light-resistant Chew-A-Treat blisters and cold sealed with foil labels. 1 Use as directed. Do not exceed prescribed dose. 6 Keep in a dry place. 2 Keep out of reach of children. 7 Protect from light. Auxiliary Labels 3 Keep at room temperature (20 C 23 C). 8 Discard container after use. 4 Consult your health care practitioner if any prescription or over-the-counter medications are currently being used or are prescribed for future use. 9 For canine use only. 5 Do not take with alcohol, sleep aids, tranquilizers or other CNS depressants. 10 May impair mental and/or physical ability. Pharmacist Instructions Add any auxiliary labels specific to the API to the dispensing container as deemed necessary. Patient Instructions Contact your pharmacist in the event of adverse reactions.

4/11/2015; Page 6 REFERENCES 1. Lozenges/Troches. In: Allen, LV, Jr. The Art, Science and Technology of Pharmaceutical Compounding Third Edition. American Pharmaceutical Association; 2008: 153. 2. Prozac. In: Canadian Pharmacists Association. Compendium of Pharmacists and Specialties, 2014: 2237. 3. Glycerin. In: Rowe RC. Handbook of Pharmaceutical Excipients, 6 th Edition. American Pharmaceutical Association; 2009: 283. 4. Fluoxetine Hydrochloride. In: Sweetman SC, ed. Martindale: The Complete Drug Reference, 36 th Edition. London, England: The Pharmaceutical Press; 2009: 391. 5. Fluoxetine (Monograph). In: O Neil MJ. The Merck Index 14 th Edition. Whitehouse Station, NJ: Merck & Co, Inc.; 2006: #4185. 6. Fluoxetine Hydrochloride. In: Trissel LA. Trissel s Stability of Compounded tions, 4th Edition. American Pharmaceutical Association; 2009: 245. 7. Fluoxetine Hydrochloride (Monograph). United States Pharmacopeia XXXVII / National ry 32. Rockville, MD. US Pharmacopeial Convention, Inc. 2014: 3035. 8. Fluoxetine Systemic. Thomson Micromedex. USP DI Drug Information for the Health Care Professional, 26 th Edition. Taunton, MA: US Pharmacopeial Convention, Inc; 2006: 1517. 9. USP <795>. United States Pharmacopeia XXXVII / National ry 32. Rockville, MD. US Pharmacopeial Convention, Inc. 2014: 403. DISCLAIMER: MEDISCA NETWORK INC., HEREBY REFERRED TO AS 'THE NETWORK', HAS PROVIDED THE FORMULA AND INSTRUCTIONS ABOVE AS A MODEL FOR EDUCATIONAL PURPOSES ONLY ON THE BASIS OF THE RECOGNIZED COMPENDIA AND TEXTS REFERENCED AT THE END OF THIS DOCUMENT. THE NETWORK TAKES NO RESPONSIBILITY FOR THE VALIDITY OR ACCURACY OF THIS INFORMATION OR FOR ITS SAFETY OR EFFECTIVENESS, NOR FOR ANY USE THEREOF, WHICH IS AT THE SOLE RISK OF THE LICENSED PHARMACIST. ADJUSTMENTS MAY BE NEEDED TO MEET SPECIFIC PATIENT NEEDS AND IN ACCORDANCE WITH A LICENSED PRESCRIBER'S PRESCRIPTION. THE PHARMACIST MUST EMPLOY APPROPRIATE TESTS TO DETERMINE THE STABILITY OF THIS SUGGESTED FORMULA. THE NETWORK CANNOT BE HELD LIABLE TO ANY PERSON OR ENTITY CONCERNING CLAIMS, LOSS, OR DAMAGE CAUSED BY, OR ALLEGED TO BE CAUSED BY, DIRECTLY OR INDIRECTLY, THE USE OR MISUSE OF THE INFORMATION CONTAINED IN THIS SUGGESTED FORMULA. IN ALL CASES IT IS THE RESPONSIBILITY OF THE LICENSED PHARMACIST TO KNOW THE LAW, TO COMPOUND ANY ISHED PRODUCT AND TO DISPENSE THESE PRODUCTS IN ACCORDANCE WITH FEDERAL AND STATE LAW.

4/11/2015; Page 1 Appendix Chewable Treat mold calibration 1. A. Weigh and / or measure the following ingredients: Preparatory Instruction Ingredient Glycerin (B), USP Stevia Powder Beef Flavor (Powder) Medisca Gelatin Gum Base Commercial Dried Dog Food Pellets Quantities 4 ml 0.12 g 1.00 g 15.66 g 31.80 g Notes: Measure the exact amount specified. Do not consider processing error for calibration step. Data in this calibration table are based on a 4.0 ml mold size. 2. Powder preparation: A. Triturate the Commercial Dried Dog Food Pellets to form a fine, homogeneous powder blend. B. By geometric addition, combine and triturate the following ingredients together to form a fine, homogeneous powder blend. -Beef Flavor (Powder) -Stevia Powder C. By geometric addition, combine and mix the following ingredients together to form a homogeneous mixture: -Fine, homogeneous powder blend (Step 2B) -Fine, homogeneous powder blend (Step 2A) D. Transfer the mixture (Step 2C) to a beaker and incrementally add the Glycerin (B). Specifications: Continuously mix until homogeneous. End result: Homogeneous moist blend. Note: The mixture will have a sand-like texture. If it begins to stick to your stirring device or beaker, you can simply scrape it off and continue mixing.

4/11/2015; Page 2 Appendix Chewable Treat mold calibration 3. Medium integration: A. Using the hot plate, heat the Gelatin Gum Base until molten. Specifications: Maintain temperature between 60 C and 65 C. IMPORTANT: Do not allow the temperature to exceed 65 C. B. Using the hot plate, incrementally add the homogeneous moist blend (Step 2D) to the Molten Gelatin Gum Base (Step 3A). Specifications: Continuously mix until homogeneous. Maintain temperature between 60 C and 65 C. End result: Homogeneous thick, sticky paste-like dispersion. 4. Mold filling: A. Lubricate all parts of the Chew-A-Treat Mold with suitable vegetable spray and set aside. Note: Selected vegetable spray needs to be compatible with API(s) and all other ingredients within the formulation. B. Properly lubricate gloves (thumbs, forefingers, and palms) throughout filling. C. Continuing to heat the mixture between 60 to 65 C, remove a marble-sized quantity of the mixture at a time and roll it between your thumb and forefinger to form a cylinder. Pack the 5 mold cavities with these cylinders and scrape off any excess with pre-lubricated plastic scraper. D. Once the treats have been packed down with an extractor, apply a thin layer of lubricant to give a shining surface. E. Allow the treats to cool at room temperature for at least 15 minutes and then remove them from the mold using the extractor.

4/11/2015; Page 3 Appendix Chewable Treat mold calibration 5. Calculate the average chewable treat weight: A. Weigh the five treats and record the total weight here (not including weight of the empty chewable treat mold): B. Calculate the average Chewable Treat weight: Combined weight of the Chewable Treat (from Step 5A) DIVIDED BY Number of Chewable Treats 5 i. Average (theoretical) Chewable Treat weight (4 ml) DIVIDED BY Volume of the Chewable Treats 4 ml ii. Average (theoretical) Chewable Treat weight (1 ml)

4/11/2015; Page 4 Appendix Chewable Treat mold calibration 6. Ingredient calculation: A. Determine the actual quantity of Chewable Treats Base required for the batch (60 Chewable Treats): Total Volume of the batch (60 x 1.0 ml) 60.0 ml MINUS Glycerin (A) from main formula 6.0 ml Quantity of Chewable Treats Base in ml 54.0 ml MULTIPLED BY Average treat weight [from Step 5Bii (g/1 ml = g/ml)] MINUS Quantity (in g) of [Fluoxetine Hydrochloride (0.336 g) + Stevia Powder (0.18 g) + Beef Flavor (1.50 g)] x 0.7 (Displacement factor) for the batch 1.4112 g i. Quantity of Chewable Treats Base required for 60 treats

4/11/2015; Page 5 Appendix Chewable Treat mold calibration 7. Ingredient calculation: A. Determine the actual quantity of Gelatin Gum Base and Commercial Dried Dog Food Pellets fraction required for the batch (60 Chewable Treats): Gelatin Gum Base fraction (6Ai ⅓) MULTIPLED BY Processing error adjustments (5 to 9%) 1.05 to 1.09 i. Weight of Gelatin Gum Base required for 60 Chewable Treats Commercial Dried Dog Food Pellets fraction (6Ai ⅔) MULTIPLED BY Processing error adjustments (5 to 9%) 1.05 to 1.09 ii. Weight of Commercial Dried Dog Food Pellets required for 60 Chewable Treats DISCLAIMER: MEDISCA NETWORK INC., HEREBY REFERRED TO AS 'THE NETWORK', HAS PROVIDED THE FORMULA AND INSTRUCTIONS ABOVE AS A MODEL FOR EDUCATIONAL PURPOSES ONLY ON THE BASIS OF THE RECOGNIZED COMPENDIA AND TEXTS REFERENCED AT THE END OF THIS DOCUMENT. THE NETWORK TAKES NO RESPONSIBILITY FOR THE VALIDITY OR ACCURACY OF THIS INFORMATION OR FOR ITS SAFETY OR EFFECTIVENESS, NOR FOR ANY USE THEREOF, WHICH IS AT THE SOLE RISK OF THE LICENSED PHARMACIST. ADJUSTMENTS MAY BE NEEDED TO MEET SPECIFIC PATIENT NEEDS AND IN ACCORDANCE WITH A LICENSED PRESCRIBER'S PRESCRIPTION. THE PHARMACIST MUST EMPLOY APPROPRIATE TESTS TO DETERMINE THE STABILITY OF THIS SUGGESTED FORMULA. THE NETWORK CANNOT BE HELD LIABLE TO ANY PERSON OR ENTITY CONCERNING CLAIMS, LOSS, OR DAMAGE CAUSED BY, OR ALLEGED TO BE CAUSED BY, DIRECTLY OR INDIRECTLY, THE USE OR MISUSE OF THE INFORMATION CONTAINED IN THIS SUGGESTED FORMULA. IN ALL CASES IT IS THE RESPONSIBILITY OF THE LICENSED PHARMACIST TO KNOW THE LAW, TO COMPOUND ANY ISHED PRODUCT AND TO DISPENSE THESE PRODUCTS IN ACCORDANCE WITH FEDERAL AND STATE LAW.